Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters

Publication year range
1.
Transfus Med ; 32(2): 153-161, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35001439

ABSTRACT

INTRODUCTION: South America is one of the regions most affected by the COVID-19 pandemic. Specific and affordable treatments are needed to treat SARS-CoV-2 infection. Evidence regarding the use of convalescent plasma in COVID-19 patients is still limited. We compared the safety and efficacy of COVID-19-convalescent plasma administration as a complement to standard treatment in the early management of patients with moderate SARS-CoV-2 infection. METHODS: We carried out a random double blinded, placebo-controlled trial that compared standard treatment plus convalescent plasma (CP) or plus non-convalescent plasma in the management of COVID-19 patients. The main outcome was survival and secondary endpoints included: length of hospitalisation (LOH), days from treatment to discharge, time to clinical improvement or death within a 28-day period, and adverse reactions to treatment. RESULTS: Administration of CP with antibodies against SARS-CoV-2 did not affect patient survival, RR = 1.003, 95% CI (0.3938, 2.555). These results led to terminate the RCT prematurely. However, early treatment of COVID-19 patients with CP tended to decrease the LOH while the delay in CP treatment was associated with longer hospitalisation. In addition, delay in CP treatment negatively affected the recovery of the respiratory rate. CONCLUSION: Use of CP for the treatment of COVID-19 patients is safe and its early use can decrease the LOH and improve respiratory function. Early administration of antibody-rich CP could contribute to decrease the negative impact of COVID-19 pandemic in patients with impaired immune response.


Subject(s)
COVID-19 , Immunization, Passive , COVID-19/therapy , Humans , Immunization, Passive/methods , Pandemics , SARS-CoV-2 , COVID-19 Serotherapy
2.
Eur J Clin Microbiol Infect Dis ; 39(7): 1365-1372, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32125555

ABSTRACT

Conventional therapy for H. pylori infection includes the combination of antibiotics and a proton-pump inhibitor. Addition of probiotics as adjuvants for H. pylori antibiotic treatment can increase eradication rate and decrease treatment side effects. Although many studies show the benefits of S. boulardii CNCM I-745 in the treatment of H. pylori infection, the mechanism by which those benefits are achieved is unknown. Here, we report clinical characteristics and fecal microbiota changes comparing conventional anti-H. pylori therapy versus conventional therapy supplemented with S. boulardii CNCM I-745. A total of 74 patients were included in the current study; patients positive for H. pylori (n = 63) were randomly assigned to 2 groups: 34 patients received conventional therapy and 29 antibiotic therapy plus 750 mg of S. boulardii CNCM I-745 daily, for 2 weeks. Eleven patients negative for H. pylori infection were also studied. Patients provided 3 fecal samples: before initiating the antibiotic treatment, upon its completion, and 1 month after treatment. Patients were contacted every 72 h to inquire about side effects and compliance. DNA was extracted, and 16S rRNA was amplified and sequenced on Illumina MiSeq. Bioinformatic analysis was performed using QIIME2. Patients who received the probiotic had a significantly lower frequency of associated gastrointestinal symptoms (P = 0.028); higher number of bacterial diversity evenness (P = 0.0156); higher abundance of Enterobacteria; and lower abundance of Bacteroides and Clostridia upon treatment completion. Addition of S. boulardii CNCM I-745 induced a lower frequency of gastrointestinal symptoms that could be related to changes in gut microbiota.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Gastrointestinal Microbiome , Helicobacter Infections/therapy , Probiotics/administration & dosage , Saccharomyces boulardii/physiology , Adult , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Feces/microbiology , Female , Gastrointestinal Microbiome/genetics , Helicobacter Infections/microbiology , Helicobacter pylori , Humans , Male , Middle Aged , RNA, Ribosomal, 16S/genetics , Treatment Outcome
3.
Helicobacter ; 25(6): e12753, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32896972

ABSTRACT

BACKGROUND: Intestinal microbiota are recognized as an organ with important physiological functions whose alterations have been associated with common diseases including inflammatory intestinal conditions, malnutrition, type-2 diabetes, and cardiovascular diseases. The composition and function of the microbiota in the distal part of the intestine has been mainly described, while there is limited information on the small intestine microbiota. The objective of the present study was to describe the duodenal microbiome in individuals with dyspepsia in the presence or absence of Helicobacter pylori gastric infection. MATERIALS AND METHODS: Thirty-eight biopsies from the proximal duodenum of uninfected and 37 from H pylori-infected individuals were analyzed. Microbiota composition was assessed by PCR amplification and sequencing of 16S rRNA and ITS genes; sequences were analyzed with QIIME2. RESULTS AND CONCLUSIONS: At the phyla level, Proteobacteria, Bacteroidetes, Firmicutes, Actinobacteria, and Fusobacteria were predominant in the mucosal associated duodenal microbiota (MAM); at the genera level, we observed the predominance of Ralstonia, Streptococcus, Pseudomonas, Haemophilus, Herbaspirillum, Neisseria, and Veillonella. Microbiota α-diversity was higher in H pylori-infected individuals than in non-infected ones. In terms of ß-diversity metrics, there was a statistically significant difference between groups. Also, relative abundance of Haemophilus, Neisseria, Prevotella pallens, Prevotella 7, and Streptococcus was greater in H pylori-infected patients. In infected patients, several types of H pylori were present in duodenal MAM. Finally, the majority of duodenal samples had fungi sequences; the most common taxa observed were Recurvomyces followed by Ascomycota and Basidiomycota.


Subject(s)
Duodenum/microbiology , Helicobacter Infections , Microbiota , Bacteria/classification , DNA, Ribosomal Spacer/genetics , Fungi/classification , Helicobacter Infections/microbiology , Helicobacter pylori , Humans , RNA, Ribosomal, 16S/genetics
4.
Rev Panam Salud Publica ; 42: e139, 2018.
Article in English | MEDLINE | ID: mdl-31093167

ABSTRACT

OBJECTIVE: To assess the feasibility of implementing a physician-based, patient-centered counseling intervention model in Ecuador to improve the ability of primary care physicians (PCPs) to reduce cardiovascular disease (CVD) risk factors among patients. METHODS: This was a randomized clinical trial conducted in primary care clinics in Quito in 2014 - 2016. Participants included 15 PCPs and their adult patients at high risk of developing type-2 diabetes. A physician-based and patient-centered counseling program was delivered to eight PCPs. Seven PCPs who did not receive the training comprised the control group. The patient experience was assessed by a patient exit interview (PEI). Assessment of the patient's anthropometrics, blood pressure, and blood biochemistry parameters were conducted. Changes within and between groups were estimated utilizing chi-square, ANOVA, paired t-tests, and coefficient with intervention. RESULTS: A total of 197 patients participated, 113 in the intervention care group (ICG) and 84 in the usual care group (UCG); 99 patients (87.6%) in the ICG and 63 (75%) in the UCG completed the study. Counseling steps, measured by the PEI, were significantly higher in the ICG (8.9±1.6 versus 6.6±2.3; P = 0.001). Comparison of the estimated difference between the ICG and the UCG showed greater decreases in HbA1c and total cholesterol in the ICG. Within the ICG, there were significant improvements in weight, BMI, HbA1C, total cholesterol, and LDL-cholesterol. CONCLUSIONS: Training PCPs in a patient-centered behavioral intervention for CVD risk factor reduction is feasible and efficacious for reducing CVD risk factors in Ecuador. Developed and developing countries alike could benefit from such an intervention.

5.
Arch Latinoam Nutr ; 66(2): 101-112, 2016 Jun.
Article in English | MEDLINE | ID: mdl-29737666

ABSTRACT

Glutamic acid or its ionic form L-glutamate (GLU) is one of the most abundant amino acids in nature and it plays important functions at the cellular and systemic levels. For instance, in the intestine and liver, GLU is a source of energy and is the precursor of key biological molecules. At the central nervous system of mammals, GLU acts as an excitatory neurotrausmitter due to the interaction with specific receptors. In addition, GLU has been related with short- and long-term potentiation, memory and the learning. Furthermore, consumption of GLU or its monosodium salt (monosodium glutamate, MSG) as a food additive is responsible for the umami taste. The consumption of MSG has been considered safe for different agencies responsible for the evaluation of the safe use of food additives, which have establish an Acceptable Daily Intake (ADI) "not specified", or classified as Generally Recognized Safe Substance (GRAS). This review focuses on important metabolic aspects of GLU and its role in food tasting and MSG safety.


Subject(s)
Glutamic Acid/chemistry , Glutamic Acid/metabolism , Taste/physiology , Central Nervous System/metabolism , Colon/metabolism , Food , Humans , Liver/metabolism , Receptors, Ionotropic Glutamate/metabolism , Receptors, Metabotropic Glutamate/metabolism
6.
Compr Rev Food Sci Food Saf ; 14(4): 431-445, 2015 Jul.
Article in English | MEDLINE | ID: mdl-27453695

ABSTRACT

Quinoa (Chenopodium quinoa Willd., Amaranthaceae) is a grain-like, stress-tolerant food crop that has provided subsistence, nutrition, and medicine for Andean indigenous cultures for thousands of years. Quinoa contains a high content of health-beneficial phytochemicals, including amino acids, fiber, polyunsaturated fatty acids, vitamins, minerals, saponins, phytosterols, phytoecdysteroids, phenolics, betalains, and glycine betaine. Over the past 2 decades, numerous food and nutraceutical products and processes have been developed from quinoa. Furthermore, 4 clinical studies have demonstrated that quinoa supplementation exerts significant, positive effects on metabolic, cardiovascular, and gastrointestinal health in humans. However, vast challenges and opportunities remain within the scientific, agricultural, and development sectors to optimize quinoa's role in the promotion of global human health and nutrition.

7.
Emerg Infect Dis ; 19(10): 1642-5, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24047566

ABSTRACT

In tropical areas, the predominant cause of fever has historically been malaria. However by 2011, among febrile patients in northwestern Ecuador, dengue was identified in 42% and malaria in none. This finding suggests a transition in the cause of fever from malaria to other illnesses, such as dengue.


Subject(s)
Dengue/epidemiology , Fever/virology , Malaria/epidemiology , Adolescent , Adult , Aged , Child , Child, Preschool , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/pathology , Communicable Diseases, Emerging/virology , Dengue/pathology , Ecuador/epidemiology , Epidemiological Monitoring , Fever/epidemiology , Fever/parasitology , Humans , Incidence , Malaria/pathology , Middle Aged , Young Adult
9.
Ann Glob Health ; 89(1): 21, 2023.
Article in English | MEDLINE | ID: mdl-37034452

ABSTRACT

Before the COVID-19 pandemic, chronic noncommunicable diseases (NCDs), represented a high burden for low and middle-income countries. Patients with NCDs are at higher risk of COVID-19 and suffer worse clinical outcomes. We present mortality trends for myocardial infarction (AMI), stroke, hypertension (HT), and type-2 diabetes mellitus (T2DM) from 2005 to 2021 in Ecuador. The greatest increase in mortality observed in the pandemic was in AMI, T2DM, and HT. Factors related to COVID-19, health services, and patients with NCDs could contribute to these important increases in mortality.


Subject(s)
COVID-19 , Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Noncommunicable Diseases , Humans , Pandemics , Ecuador/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Noncommunicable Diseases/epidemiology , Cardiovascular Diseases/epidemiology
10.
Pain Manag ; 13(12): 689-699, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38193278

ABSTRACT

Background: There are limited data on non-oncological high-impact chronic pain (HICP) in Ecuador; we report the epidemiological characteristics of HICP. Materials & methods: In this cross-sectional study, we included a random sample of adult individuals who had cell phones. Results & conclusion: The weighted prevalence of HICP was 9.0%: 12.3% for women and 5.6% for men (p = 0.001). HICP was more frequently localized in the lower back and affected the economically active population. Nonsteroidal anti-inflammatory drugs were more commonly used; however, 61% of patients indicated that the effectiveness of their management was low. Overall, HICP had a negative impact on daily life activities. The effectiveness of the current treatment was low and should include an integrated approach.


We report the frequency, characteristics and associated factors of non-cancer high-impact chronic pain (HICP) in Ecuador. HICP refers to pain that has been felt constantly in the last 3 months. Women were more often affected, and the pain was more commonly localized in the lower back. Most patients indicated that their pain treatment was poor. HICP was common and had a negative impact on daily life activities. The current treatment of HICP must consider the physical and mental aspects of the people who suffer from it; this requires a combination of treatments such as drugs, exercise, physical rehabilitation and mind­body interventions.


Subject(s)
Chronic Pain , Adult , Male , Humans , Female , Chronic Pain/epidemiology , Cross-Sectional Studies , Ecuador/epidemiology , Anti-Inflammatory Agents, Non-Steroidal , Research Design
11.
Nat Neurosci ; 26(7): 1208-1217, 2023 07.
Article in English | MEDLINE | ID: mdl-37365313

ABSTRACT

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by heterogeneous cognitive, behavioral and communication impairments. Disruption of the gut-brain axis (GBA) has been implicated in ASD although with limited reproducibility across studies. In this study, we developed a Bayesian differential ranking algorithm to identify ASD-associated molecular and taxa profiles across 10 cross-sectional microbiome datasets and 15 other datasets, including dietary patterns, metabolomics, cytokine profiles and human brain gene expression profiles. We found a functional architecture along the GBA that correlates with heterogeneity of ASD phenotypes, and it is characterized by ASD-associated amino acid, carbohydrate and lipid profiles predominantly encoded by microbial species in the genera Prevotella, Bifidobacterium, Desulfovibrio and Bacteroides and correlates with brain gene expression changes, restrictive dietary patterns and pro-inflammatory cytokine profiles. The functional architecture revealed in age-matched and sex-matched cohorts is not present in sibling-matched cohorts. We also show a strong association between temporal changes in microbiome composition and ASD phenotypes. In summary, we propose a framework to leverage multi-omic datasets from well-defined cohorts and investigate how the GBA influences ASD.


Subject(s)
Autism Spectrum Disorder , Gastrointestinal Microbiome , Humans , Gastrointestinal Microbiome/genetics , Brain-Gut Axis , Autism Spectrum Disorder/genetics , Autism Spectrum Disorder/metabolism , Cross-Sectional Studies , Bayes Theorem , Reproducibility of Results , Cytokines
12.
PLoS One ; 16(7): e0254812, 2021.
Article in English | MEDLINE | ID: mdl-34297755

ABSTRACT

Metabolic syndrome (MetS) and type 2 diabetes (T2D) are metabolic alterations associated with high morbidity and mortality, particularly in low and middle-income countries. Diet has a significant impact on the risk to develop MetS and T2D; in this regard, consumption of fruits, vegetables, and protein rich foods (from plant and animals) are important to prevent and manage these pathologies. There are limited studies regarding the potential association between Andean foods rich in proteins and the presence of cardio-metabolic conditions in Ecuador. It is necessary to develop new low-cost, local-culturally acceptable strategies to reduce the burden of cardio-metabolic diseases. We describe the prevalence (baseline data) of MetS and T2D in the Ecuadorian cohort of the Prospective Urban and Rural Epidemiology (PURE) study and their potential association with the consumption of protein rich foods, including beef, white meat, dairy and legumes. In this cross-sectional study, we assessed 1,997 individuals aged 35-70 years (mean age 51 years, 72% women), included in the Ecuadorian cohort of the PURE study, from February to December 2018. The prevalence of MetS was 42% for male and 44% for female participants; the prevalence of T2D was 9% for male and 10% for female. Metabolic syndrome and T2D were more common in women older than 50 years of age with primary education or less, low economic income, and with obesity; MetS was more frequent in the rural area while T2D was more frequent in the urban area. Using logistic regression analysis, we observed a significant protective effect of higher consumption of dairy and legumes in the prevalence of MetS and T2D compared with low consumption. It will be important to develop policies for ample production and consumption of protein rich foods such as legumes and dairy, part of traditional diets, to reduce the burden of cardio-metabolic diseases.


Subject(s)
Diabetes Mellitus, Type 2/epidemiology , Diet/statistics & numerical data , Metabolic Syndrome/epidemiology , Adult , Aged , Dairy Products/statistics & numerical data , Diet/adverse effects , Dietary Fiber/statistics & numerical data , Ecuador , Fabaceae , Female , Humans , Male , Meat Products/statistics & numerical data , Middle Aged , Socioeconomic Factors
13.
J Clin Hypertens (Greenwich) ; 22(9): 1530-1537, 2020 09.
Article in English | MEDLINE | ID: mdl-33245617

ABSTRACT

The major burden of hypertension (HTN) occurs in low-middle-income countries (LMIC) and it is the main modifiable risk factor for cardiovascular diseases (CVD). Few population studies on HTN prevalence have been carried out in Ecuador where there is limited information regarding its prevalence, awareness, treatment, and control. Thus, the aim of the present study was to determine the prevalence, awareness, treatment, and control of HTN and its association with socio-economic, nutritional, and lifestyle habits in urban and rural Andean communities of Pichincha province in Ecuador. The authors studied 2020 individuals aged 35-70 years (mean age 50.8 years, 72% women), included in the Ecuadorian cohort of the Prospective Urban and Rural Epidemiology (PURE) study, from February to December 2018. The hypertension prevalence (>140/90 mmHg) was 27% and was greater in urban than in rural communities, more common in men, in individuals older than 50 years of age, in people with low monthly income and low level of education. Higher prevalence was also observed in subjects with obesity, and among former smokers and those who consumed alcohol. Only 49% of those with HTN were aware of their condition, 40% were using antihypertensive medications, and 19% had their blood pressure under control (<140/90 mmHg). These results showed low levels of awareness, treatment, and control of HTN in the Andean region of Ecuador, suggesting the urgent necessity of implementing programs to improve the diagnosis and management of HTN.


Subject(s)
Hypertension , Adult , Aged , Antihypertensive Agents/pharmacology , Antihypertensive Agents/therapeutic use , Awareness , Blood Pressure/drug effects , Cross-Sectional Studies , Ecuador/epidemiology , Female , Health Knowledge, Attitudes, Practice , Humans , Hypertension/diagnosis , Hypertension/drug therapy , Hypertension/epidemiology , Male , Middle Aged , Prevalence , Prospective Studies , Risk Factors
14.
Gut Microbes ; 11(3): 453-464, 2020 05 03.
Article in English | MEDLINE | ID: mdl-31530087

ABSTRACT

Most studies on autism spectrum disorder (ASD) risk factors have been conducted in developed countries where ethnicity and environment are different than in developing countries. We compared nutritional status, immune response and microbiota composition in mestizo children with ASD with matched controls in Ecuador. Twenty-five cases and 35 controls were matched by age, sex and school location. The prevalence of under- and overweight was higher in children with ASD. Nutritional differences were accompanied by abnormal food habits and more frequent gastrointestinal symptoms in children with ASD. Also, greater serum concentrations of TGF-ß1 were observed in children with ASD. Finally, there was greater alpha diversity and abundance of Bacteroides (2 OTUs), Akkermansia, Coprococcus and different species of Ruminococcus in ASD children.


Subject(s)
Autism Spectrum Disorder/immunology , Autism Spectrum Disorder/microbiology , Cytokines/blood , Gastrointestinal Microbiome , Immunity , Nutritional Status , Case-Control Studies , Child , Child, Preschool , DNA, Bacterial , Ecuador , Female , Humans , Male , Prevalence , Risk Factors , Sequence Analysis , Transforming Growth Factor beta1/blood
15.
Nutrients ; 11(9)2019 Sep 17.
Article in English | MEDLINE | ID: mdl-31533347

ABSTRACT

BACKGROUND: There is a growing interest regarding the physiological role of free amino acids (FAA) present in human milk (HM). Recent studies show FAA in HM could be influenced by infants' gender and could have an important role in their growth and development. We studied the concentrations of FAA in HM and potential associations with infants' gender and their patterns of growth in a cohort of Ecuadorian women. METHODS: Human milk samples were collected after approximately eight hours of overnight fast within one week (colostrum), 2 weeks (transition milk), and 2 and/or 4 months (mature milk) after parturition. Free AA were determined by cation-exchange chromatography separation. RESULTS: We observed significantly higher concentrations of Glu 14.40 (1.35, 27.44), Gly 1.82 (0.24, 3.4), Cys 0.36 (0.03, 0.68), and Tyr 0.24 (0.02, 0.46) in HM intended for boys. Free Glu, Gly, Cys, and Tyr concentrations increased with time of lactation. In addition, there were higher concentrations of Glu 28.62 (1.78, 55.46) and Ala 7.16 (1.26, 13.06) in HM for children that presented faster weight gain than for those with slower gain. CONCLUSIONS: The present results showed that there are differences in FAA levels in HM intended for male and fast-growing children.


Subject(s)
Amino Acids/metabolism , Breast Feeding , Child Development , Lactation , Milk, Human/metabolism , Nutritive Value , Weight Gain , Adolescent , Age Factors , Ecuador , Female , Humans , Infant , Infant, Newborn , Male , Prospective Studies , Sex Factors , Young Adult
16.
J Glob Antimicrob Resist ; 19: 328-332, 2019 12.
Article in English | MEDLINE | ID: mdl-31116967

ABSTRACT

OBJECTIVES: Klebsiella pneumoniae is an opportunistic pathogen associated with nosocomial infections worldwide. Isolates with a K. pneumoniae carbapenemase (KPC)-producing phenotype show reduced susceptibility to first-choice antibiotics. Between 2012-2013, the largest public tertiary-care hospital in Quito (Ecuador) reported an outbreak of KPC-producing bacteria with more than 800 cases. We developed a molecular epidemiological approach to analyse the clonality of K. pneumoniae isolates recovered from selected hospital services and patient samples. METHODS: A retrospective cohort study was performed based on microbial isolates and their corresponding records from the hospital and referred to Instituto Nacional de Investigación en Salud Pública (INSPI). From 800 isolates that were collected between 2012-2013, a total of 100 isolates were randomly selected for this study. Antimicrobial susceptibility testing was performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Genotypic detection and phylogenetic relationship analysis were performed by multilocus sequence typing (MLST). The blaKPC carbapenemase gene was also amplified by PCR and was sequenced using Sanger sequencing. RESULTS: Molecular analysis showed that the outbreak had a polyclonal origin with two predominant genotypes, comprising sequence types ST25 and ST258, present in 38 and 36 cases, respectively. These genotypes were found in all studied hospital services including general surgery, intensive care unit and emergency. TheblaKPC-5 gene was the most prevalent blaKPC variant in this study. CONCLUSION: These data indicate that KPC-producing polyclonal K. pneumoniae are frequent causes of nosocomial hospital outbreaks in South America. Similar genotypes have been reported in Colombia, Argentina, Brazil, North America and Asia.


Subject(s)
Bacterial Proteins/genetics , Cross Infection/microbiology , Disease Outbreaks , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/classification , beta-Lactamases/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Cross Infection/epidemiology , DNA, Bacterial/genetics , Ecuador/epidemiology , Female , Genotype , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/enzymology , Male , Middle Aged , Multilocus Sequence Typing , Phylogeny , Retrospective Studies , Tertiary Care Centers/statistics & numerical data , Young Adult
17.
Nutr Hosp ; 36(4): 905-911, 2019 Aug 26.
Article in English | MEDLINE | ID: mdl-31291739

ABSTRACT

INTRODUCTION: Introduction: therapeutic lifestyles changes including frequent consumption of legumes have resulted in improved metabolic control and decreased blood pressure in type 2 diabetes-mellitus (T2DM) patients. Objective: this was a quasi-experimental-28-week crossover-study that assessed the effect of daily consumption of the legume Lupinus mutabilis (LM) on metabolic control of T2DM patients under hypoglycemic oral treatment. Material and methods: we recruited 79 adult male and female patients that were followed for 14-weeks without LM consumption and then received increasing doses of a LM-based-snack for other 14-weeks. Results: there was a significant decrease in blood pressure and a significant increase in HDL-cholesterol by the end of the study period. While patients with A1C concentrations > 8 and ≤ 10 did not significantly improve their metabolic control, patients with serum A1C concentrations ≤ 8.0% reduced significantly their A1C after the intervention and 71% achieved a target concentration of 6.5%. Conclusion: patients with T2DM could benefit with the addition of LM-snack to their conventional treatment.


INTRODUCCIÓN: Introducción: los cambios recomendados sobre los estilos de vida, incluido el consumo frecuente de leguminosas, han resultado en un mejor control metabólico y disminución de la presión arterial en pacientes con diabetes mellitus tipo 2 (DMT2). Objetivo: este fue un estudio casi experimental cruzado de 28 semanas que evaluó el efecto del consumo diario de la leguminosa Lupinus mutabilis Sweet (LM) en el control metabólico de pacientes con DMT2 con tratamiento oral hipoglucemiante. Material y métodos: inicialmente se reclutaron 79 pacientes adultos, hombres y mujeres, que fueron seguidos durante 14 semanas sin consumo de LM y luego recibieron dosis crecientes de un tentempié de LM durante otras 14 semanas. Resultados: se observó una disminución significativa en la presión arterial y un aumento significativo en el colesterol-HDL después del consumo de LM. Mientras que los pacientes con concentraciones de A1C sérica > 8 y ≤ 10 no mejoraron significativamente su control metabólico, los pacientes con concentraciones séricas de A1C ≤ 8,0% redujeron significativamente su A1C después de la intervención y el 71% de estos pacientes llegó a la meta de tratamiento ≤ 6,5%. Conclusión: los pacientes con DMT2 podrían beneficiarse con la adición de un tentempié de LM a su tratamiento convencional.


Subject(s)
Diabetes Mellitus, Type 2/diet therapy , Lupinus , Phytotherapy/methods , Snacks , Blood Glucose , Blood Pressure Determination , Cholesterol, HDL/blood , Combined Modality Therapy/methods , Cross-Over Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Female , Glycated Hemoglobin/analysis , Humans , Hypoglycemic Agents/therapeutic use , Life Style , Male , Middle Aged
18.
Arch Latinoam Nutr ; 58(2): 139-43, 2008 Jun.
Article in Spanish | MEDLINE | ID: mdl-18833990

ABSTRACT

This is the first study to establish the prevalence of overweight and obesity among Ecuadorian adolescent students. The population studied was made up of 2.829 students, 1.461 females and 1.368 males between 12 and <19 years of age. One thousand four hundred and thirty five students were registered in 60 schools, public and private, in the six main cities of the Coastal Region; the remaining 1.394 students were registered in 60 schools, public and private, in the six main cities in the Andean Region. Height and weight were measured in all participants and the body mass index (BMI) of each individual was calculated. Overweight was diagnosed in those adolescents whose BMI was between percentiles 85 and < 95, and obesity was diagnosed in the subjects whose BMI was > 95. Results indicate that 21.2% of adolescents had excess weight: 13.7% were overweight and 7.5% had obesity. Excess weight was higher in the Coast (24.7%) than in the Andean Region (17.7%; P < 0.0001). In the same way, excess weight was higher among students attending private schools (25,3%) than in those attending public schools (18.9%; P < 0.0001). Data also indicate that excess weight was more common in women than in men, 21.5% versus 20.8%, respectively (P < 0.02). The study also indicated that 16.8% of adolescents were underweight. Taken together, these data indicate that 38% of the studied population was malnourished. It is necessary to take measures to prevent and treat these important public health problems in Ecuador.


Subject(s)
Obesity/epidemiology , Adolescent , Body Mass Index , Ecuador/epidemiology , Female , Humans , Male , Overweight/epidemiology , Prevalence , Sex Distribution , Urban Population
19.
Arch Latinoam Nutr ; 58(1): 5-11, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18589566

ABSTRACT

Weaning during infancy refers to the initiation of complementary food to breast milk. During weaning, there are significant changes on the gastrointestinal microbiota. Deleterious alterations of the gastrointestinal microbiota can result in pathological processes while measures that stimulate its development and stability, like the use of probiotics, are beneficial. The mechanisms by which probiotics achieve their effects have not been clearly established. Present work compares the microbial composition of feces from infants that were weaned to regular family food, formula with probiotics (B. Lactis BL y S. Thermophilus) or formula without probiotics. Accordingly, analysis of rDNA of microbial fecal samples by molecular techniques was used. Formula with or without probiotics was well tolerated and safe for all participating children. Probiotics present in formula were viable and susceptible to culture. There was not difference on physical growth or development among all participants. The microbiota of children supplemented with formula with- or without probiotics was different than that observed in children supplemented with regular food. It was not possible to determine enrichment of B. Lactis BL and S. Thermophilus in the feces of children that consumed the probiotics. Present work contributes to the understanding of probiotics effects in human health.


Subject(s)
Bifidobacterium , Infant Formula , Intestines/microbiology , Nutritional Status , Probiotics/administration & dosage , Streptococcus thermophilus , Bifidobacterium/growth & development , Bifidobacterium/isolation & purification , Electrophoresis, Polyacrylamide Gel , Feces/microbiology , Female , Humans , Infant , Male , Peru , Polymerase Chain Reaction , Streptococcus thermophilus/growth & development , Streptococcus thermophilus/isolation & purification
20.
J Med Entomol ; 54(6): 1704-1711, 2017 11 07.
Article in English | MEDLINE | ID: mdl-28981860

ABSTRACT

The detection and identification of natural infections in sand flies by Leishmania protozoan species in endemic areas is a key factor in assessing the risk of leishmaniasis and in designing prevention and control measures for this infectious disease. In this study, we analyzed the Leishmania DNA using nuclear ribosomal internal transcript spacer (ITS) sequences. Parasite DNA was extracted from naturally infected, blood-fed sand flies collected in nine localities considered leishmaniasis-endemic foci in Ecuador.The species of parasites identified in sand flies were Leishmania major-like, Leishmania naiffi, Leishmania mexicana, Leishmania lainsoni, and "Leishmania sp. siamensis". Sand fly specimens of Brumptomyia leopoldoi, Mycropigomyia cayennensis, Nyssomyia yuilli yuilli, Nyssomyia trapidoi, Pressatia triacantha, Pressatia dysponeta, Psychodopygus carrerai carrerai, Psychodopygus panamensis, and Trichophoromyia ubiquitalis were found positive for Leishmania parasite. These findings contribute to a better understanding of the epidemiology and transmission dynamics of the disease in high-risk areas of Ecuador.


Subject(s)
Insect Vectors/parasitology , Leishmania/isolation & purification , Psychodidae/parasitology , Animals , DNA, Intergenic , Ecuador , Female , Leishmania/classification , Leishmania/genetics
SELECTION OF CITATIONS
SEARCH DETAIL